Insider Shareholders with Direct Ownership of Bellerophon Therapeutics, Inc. (BLPH)
This section provides a comprehensive overview of the insiders with direct ownership of Bellerophon Therapeutics, Inc. (BLPH). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Bellerophon Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Puissance Life Science Opportunities Fund Vi
> 10% Shareholder |
617,420 | 694,421 | 1,076,841 $43,073 | 4 |
Jun 07, 2023
Reduced 11.1%
|
| 0 | 400,000 | 609,231 $24,369 | 1 |
Mar 18, 2021
Reduced 39.63%
|
|
|
Naseem Amin
Director |
170,610 | 0 | 291,865 $11,674 | 3 |
Jun 07, 2023
Added 14.02%
|
| 15,308 | 0 | 157,033 $6,281 | 1 |
Mar 31, 2021
Added 8.88%
|
|
|
Peter Fernandes
Officer |
32,500 | 9,985 | 22,515 $900 | 2 |
Dec 09, 2022
Reduced 30.72%
|
|
Martin Dekker
Officer |
25,500 | 7,834 | 17,666 $706 | 2 |
Dec 09, 2022
Reduced 30.72%
|
|
Parag Suresh Shah
VP of Business Operations |
25,500 | 7,834 | 17,666 $706 | 2 |
Dec 09, 2022
Reduced 30.72%
|
|
Nicholas Laccona
FINANCIAL OFFICER, (PFO & PAO) |
18,000 | 5,530 | 12,470 $498 | 2 |
Dec 09, 2022
Reduced 30.72%
|
|
Bobae Kim
VP Reg. Affairs & Quality |
1,288 | 9,455 | 1,723 $68 | 2 |
May 18, 2023
Reduced 84.59%
|
|
Puissance Capital Management Lp
> 10% Shareholder |
0 | 1,076,841 | 0 $0 | 1 |
Oct 13, 2023
Reduced 100.0%
|